CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13 | -50.0% | 7,828 | -16.2% | 0.00% | – |
| Q2 2023 | $26 | -81.6% | 9,346 | -67.1% | 0.00% | – |
| Q1 2023 | $141 | -55.4% | 28,434 | -3.4% | 0.00% | – |
| Q4 2022 | $316 | -99.8% | 29,434 | +66.3% | 0.00% | – |
| Q3 2022 | $166,000 | -48.4% | 17,696 | -49.8% | 0.00% | – |
| Q2 2022 | $322,000 | -35.1% | 35,231 | -13.7% | 0.00% | – |
| Q1 2022 | $496,000 | -74.8% | 40,809 | -74.7% | 0.00% | – |
| Q4 2021 | $1,966,000 | +151.4% | 161,346 | +218.2% | 0.00% | – |
| Q3 2021 | $782,000 | +99.0% | 50,701 | +84.2% | 0.00% | – |
| Q2 2021 | $393,000 | -54.7% | 27,520 | -31.1% | 0.00% | – |
| Q1 2021 | $867,000 | +245.4% | 39,914 | +140.6% | 0.00% | – |
| Q4 2020 | $251,000 | -11.0% | 16,589 | -25.0% | 0.00% | – |
| Q3 2020 | $282,000 | -47.4% | 22,105 | -29.5% | 0.00% | – |
| Q2 2020 | $536,000 | +148.1% | 31,340 | +92.0% | 0.00% | – |
| Q1 2020 | $216,000 | -80.6% | 16,320 | -76.4% | 0.00% | -100.0% |
| Q4 2019 | $1,114,000 | +4.1% | 69,209 | +18.3% | 0.00% | 0.0% |
| Q3 2019 | $1,070,000 | +62.9% | 58,527 | +91.6% | 0.00% | – |
| Q2 2019 | $657,000 | -48.2% | 30,550 | -52.8% | 0.00% | -100.0% |
| Q1 2019 | $1,269,000 | +31.6% | 64,667 | -12.7% | 0.00% | 0.0% |
| Q4 2018 | $964,000 | +32.1% | 74,098 | +142.9% | 0.00% | – |
| Q3 2018 | $730,000 | -80.7% | 30,507 | -84.5% | 0.00% | -100.0% |
| Q2 2018 | $3,781,000 | +3719.2% | 197,432 | +2336.8% | 0.00% | – |
| Q1 2018 | $99,000 | -59.4% | 8,102 | -59.4% | 0.00% | – |
| Q4 2017 | $244,000 | -79.2% | 19,938 | -76.7% | 0.00% | -100.0% |
| Q3 2017 | $1,174,000 | -31.6% | 85,715 | -23.2% | 0.00% | -50.0% |
| Q2 2017 | $1,717,000 | -2.7% | 111,589 | +16.2% | 0.00% | +100.0% |
| Q1 2017 | $1,765,000 | +184.7% | 96,002 | +43.8% | 0.00% | 0.0% |
| Q4 2016 | $620,000 | +61900.0% | 66,743 | +50462.9% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 132 | -69.2% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 429 | +73.0% | 0.00% | – |
| Q1 2016 | $2,000 | -94.3% | 248 | -88.4% | 0.00% | – |
| Q4 2015 | $35,000 | -73.7% | 2,140 | -77.6% | 0.00% | – |
| Q3 2015 | $133,000 | +2560.0% | 9,548 | +2293.0% | 0.00% | – |
| Q2 2015 | $5,000 | 0.0% | 399 | -11.5% | 0.00% | – |
| Q1 2015 | $5,000 | +25.0% | 451 | +10.8% | 0.00% | – |
| Q4 2014 | $4,000 | +300.0% | 407 | +129.9% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 177 | +105.8% | 0.00% | – |
| Q2 2014 | $1,000 | -66.7% | 86 | -41.5% | 0.00% | – |
| Q1 2014 | $3,000 | – | 147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |